TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.
March 1988 in “Archives of Dermatology” Minoxidil therapy can help with hair regrowth, but results vary and some people are just happy to stop further hair loss.
August 2016 in “International journal of scientific research” Using minoxidil with finasteride in a cream helps maintain hair thickness after stopping oral finasteride.
16 citations
,
July 1988 in “International Journal of Dermatology” The 2% minoxidil solution is safe and effective for treating male pattern baldness.
June 2024 in “Archives of dermatological research” Both treatments work, but Minoxidil 0.5% MMP® is better for certain scalp areas and less advanced hair loss.
2 citations
,
November 1987 in “Archives of Dermatology” Minoxidil solution helps regrow hair in men with hair loss, with most improvement seen at 12 months and effects lasting over 30 months.
January 2016 in “Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)” Topical finasteride formulations can treat hair loss effectively with fewer side effects.
10 citations
,
November 1993 in “Indian Journal of Dermatology Venereology and Leprology” Minoxidil can cause erythema multiforme, even if patch tests are negative.
June 2022 in “IP Indian journal of clinical and experimental dermatology” Both treatments were equally effective in promoting hair growth.
1 citations
,
June 2004 in “Sexuality, reproduction & menopause” Eflornithine cream effectively reduces facial hair in women with hirsutism.
20 citations
,
September 2015 in “Journal of The European Academy of Dermatology and Venereology” Minoxidil foam promotes hair growth and reduces hair loss safely in men.
12 citations
,
January 2012 in “Dermatology” Finasteride helped treat a 28-year-old's facial skin condition.
January 1987 in “Chronica Dermatologica”
19 citations
,
December 1985 in “Journal of The American Academy of Dermatology” Minoxidil can cause scalp comedones and acne.
March 2026 in “International Society of Hair Restoration Surgery” Minoxidil is a safe, FDA-approved treatment for hair loss, available in topical and possibly low-dose oral forms.
September 2025 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil may be a promising alternative to topical minoxidil for hair loss.
Topical finasteride may better target hair follicles without significant benefits over oral form.
March 2025 in “BioNanoScience” The new minoxidil hydrogel improves delivery and is safe for treating hair loss.
March 2023 in “Reactions Weekly” January 2023 in “Reactions Weekly” January 2023 in “Reactions Weekly” January 2023 in “Reactions Weekly”
5 citations
,
October 1993 in “International Journal of Dermatology” Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.
June 2015 in “Reactions weekly” December 2012 in “Reactions weekly”
April 2024 in “AAPS PharmSciTech” New microneedle method improves hair regrowth treatment delivery.
December 2009 in “Digital Library of Theses and Dissertations (Universidade de São Paulo)” Iontophoresis and chitosan microparticles improve minoxidil delivery for hair loss treatment.
57 citations
,
July 1987 in “Journal of The American Academy of Dermatology” Stopping minoxidil treatment resumes balding; continuous use needed for results.
17 citations
,
March 1985 in “Acta Dermato Venereologica” 1% topical minoxidil helped some hair regrow, but only one person had noticeable results.
4 citations
,
January 2015 in “Journal of drug assessment” Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.